Weaver Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,803
Closed -$1.16M 198
2025
Q2
$1.16M Sell
12,803
-704
-5% -$64.3K 0.28% 84
2025
Q1
$1.27M Sell
13,507
-280
-2% -$25.1K 0.33% 79
2024
Q4
$1.25M Sell
13,787
-462
-3% -$44.1K 0.35% 81
2024
Q3
$1.48M Sell
14,249
-1,190
-8% -$121K 0.44% 70
2024
Q2
$1.5M Sell
15,439
-438
-3% -$40.4K 0.48% 62
2024
Q1
$1.43M Buy
15,877
+3,183
+25% +$270K 0.49% 65
2023
Q4
$1.01M Buy
+12,694
New +$954K 0.4% 76

Other funds holding CL

Weaver Capital Management's CL Position: Q3 2025 in Review

Weaver Capital Management sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 12,803 shares — an estimated $1.16M sold.

Weaver Capital Management first reported a position in CL in Q4 2023 and held it in 7 quarters. The position peaked at $1.5M in Q2 2024. 1,842 funds tracked by Wall St. Rank hold CL as of Q3 2025.

  • Weaver Capital Management reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
  • Weaver Capital Management sold 12,803 Colgate-Palmolive shares in Q3 2025, an estimated $1.16M.
  • Weaver Capital Management first reported a position in Colgate-Palmolive in Q4 2023 and held it in 7 quarters.
  • Weaver Capital Management's Colgate-Palmolive position peaked at $1.5M in Q2 2024.
  • 1,842 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.

Based on Weaver Capital Management's 13F filing for Q3 2025, filed 20 Oct 2025.